R. Montironi et al., SUBTLE CHANGES IN BENIGN TISSUE ADJACENT TO PROSTATE NEOPLASIA DETECTED WITH A BAYESIAN BELIEF NETWORK, Journal of pathology, 182(4), 1997, pp. 442-449
The aim of this paper was to test the usefulness of a Bayesian belief
network (BBN) as a decision support system in the uncertainty assessme
nt of benign prostatic tissue, either associated or not with inflammat
ion or adjacent to prostatic adenocarcinoma (PAC) or prostatic intraep
ithelial neoplasia (PIN). A shallow network was used with eight first-
level descendant nodes for the diagnostic clues, each independently li
nked by a conditional probability matrix to a root node containing the
diagnostic alternatives, One diagnostic evidence node was based on th
e tissue architecture and the others were based on cell features, The
efficacy of the network was tested on a series of 45 simple prostatect
omy; specimens, subdivided as follows: benign prostatic tissue not ass
ociated with ether diseases (15 cases), associated with acute and/or c
hronic inflammation (15 cases), and adjacent to accidentally discovere
d PAC or PIN (15 cases), The highest belief values for the diagnostic
alternative normal prostate (NP) were obtained in the 15 cases not ass
ociated with other diseases, the mean value being 0.996, The 15 cases
evaluated in areas with inflammation showed the lowest belief values f
or NP (mean 0.774), For the 15 cases evaluated in specimens with PAC o
r PIN, the belief values for NP were intermediate between those from n
ormal prostatic tissue associated with inflammation and those not asso
ciated (mean 0.925), Moreover, it was found that subtle changes were a
lso present at a certain distance from the tumour, In conclusion, the
network can be used as a decision support system to differentiate with
high certainty benign prostate adjacent to PAC or PIN from benign pro
static tissue either associated or not with inflammation. The subtle m
orphological alterations detected with the BBN may be considered malig
nancy-associated changes, (C) 1997 by John Wiley & Sons, Ltd.